Marrow
PrivateLast Round
Pre Seed
Oct 22, 2026
Total Funding Raised
$2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Marrow operates in AI, Data & Cloud Infrastructure and is based in London. Its latest recorded funding round was a Pre Seed round in October 2026.
Marrow is an insurtech company that provides a standardized, compliance-grade infrastructure layer connecting AI agents to insurer pricing and underwriting systems.
Sector
AI, Data & Cloud Infrastructure
Verticals
InsurTech, NLP & Conversational AI, Compliance & Risk, API Management, Data Integration
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Marrow Comparables
Compare Marrow with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kasko | 69% | |
| Root | 66% | |
| Harbor | 65% |
For institutional investors. Book with your work email.
Marrow Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Marrow Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leo Capital | Pre Seed |
| Portfolio Ventures | Pre Seed |
| Seed X | Pre Seed |
| Insurtech Gateway | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2026
$2M round led by Insurtech Gateway.
For institutional investors. Book with your work email.
Marrow Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Marrow's valuation, stock price, and market status.
Is Marrow a public or private company?
Marrow is a private company.
What is the current stock price of Marrow?
Marrow is a private company, so its shares have no public market price. Caplight tracks Marrow's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Marrow worth (valuation)?
Valuation information for Marrow is not publicly available.
Can I buy Marrow stock?
Marrow shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Marrow's last funding round?
Marrow's most recent funding round was Pre Seed on October 22, 2026.
Who are the main investors in Marrow?
Key investors in Marrow include Insurtech Gateway.
Will Marrow IPO soon?
No public IPO plans have been announced for Marrow.
How can I track Marrow secondary market activity?
Caplight tracks bids, offers, and trades in Marrow's shares on secondary markets.